Melanoma in people aged 65 and over in Scotland, 1979-89
- PMID: 1571680
- PMCID: PMC1881622
- DOI: 10.1136/bmj.304.6829.746
Melanoma in people aged 65 and over in Scotland, 1979-89
Abstract
Objective: Detailed analysis of primary cutaneous melanoma first diagnosed in Scotland in patients aged 65 and over.
Design: Comparison of changing incidence, sex distribution, site, histogenetic type, tumour thickness, and prognosis of all primary cutaneous melanomas in patients aged 65 and over diagnosed in Scotland in the 11 years 1979-89 with similar data for patients aged under 65.
Setting: Data were obtained from the Scottish Melanoma Group's database, established in 1979, which aims to record detailed clinical, pathological, and surgical follow up details of all primary cutaneous melanomas registered in Scotland.
Patients: 1430 patients (954 women, 476 men) aged 65 and over; comprising over a third of the 3903 patients with primary melanoma recorded for all age groups in Scotland during this period.
Results: The overall incidence of melanoma in patients aged 65 and over increased from 12.2/100,000 in 1979 to 20.7/100,000 in 1989, with the greatest increase seen in older men, from 7.8/100,000 in 1979 to 18.0/100,000 in 1989. The site most commonly affected was the face in both men and women (33% of all tumours). The most common histogenetic type was superficial spreading melanoma. 526 patients (37%) had melanomas with a tumour thickness of 3.5 mm or greater in the older age group, compared with 453 patients (18%) in those aged under 65. The highest proportion of thick tumours was seen in older men. Five year survival figures for 616 patients diagnosed between 1979 and 1984 were 88%, 66%, and 47% for thin, intermediate, and thick tumours respectively. Overall five year survival for the older age group was 64% compared with 78% for the younger age group.
Conclusion: The increase in melanoma in the elderly and the high proportion of thick tumours, especially in men, require a specific educational programme for both primary and secondary prevention directed towards the older population.
Comment in
-
Melanoma in people aged 65 and over.BMJ. 1992 Apr 18;304(6833):1055. doi: 10.1136/bmj.304.6833.1055-b. BMJ. 1992. PMID: 1586802 Free PMC article. No abstract available.
Similar articles
-
Cutaneous malignant melanoma, Scotland, 1979-89. The Scottish Melanoma Group.Lancet. 1992 Apr 18;339(8799):971-5. doi: 10.1016/0140-6736(92)91539-k. Lancet. 1992. PMID: 1348807
-
Malignant melanoma in Scotland 1979-1983.Lancet. 1985 Oct 19;2(8460):859-63. doi: 10.1016/s0140-6736(85)90126-6. Lancet. 1985. PMID: 2864579
-
Thick melanoma: the challenge persists.Br J Dermatol. 2005 Jan;152(1):104-9. doi: 10.1111/j.1365-2133.2005.06409.x. Br J Dermatol. 2005. PMID: 15656809
-
Are all melanomas dangerous?Acta Derm Venereol. 2011 Sep;91(5):499-503. doi: 10.2340/00015555-1177. Acta Derm Venereol. 2011. PMID: 21874217 Review.
-
Cutaneous melanoma.Cancer Surv. 1994;19-20:219-40. Cancer Surv. 1994. PMID: 7534627 Review.
Cited by
-
Melanoma and sunburn.Cancer Causes Control. 1994 Nov;5(6):564-72. doi: 10.1007/BF01831385. Cancer Causes Control. 1994. PMID: 7827244 Review.
-
Melanoma risk factors and atypical moles.West J Med. 1994 Apr;160(4):343-50. West J Med. 1994. PMID: 8023484 Free PMC article. Review.
-
Melanoma in people aged 65 and over.BMJ. 1992 Apr 18;304(6833):1055. doi: 10.1136/bmj.304.6833.1055-b. BMJ. 1992. PMID: 1586802 Free PMC article. No abstract available.
-
Age as a prognostic factor in the malignant melanoma population.Ann Surg Oncol. 1994 Nov;1(6):487-94. doi: 10.1007/BF02303614. Ann Surg Oncol. 1994. PMID: 7850555
-
Clinical-histological characteristics and therapeutic management of primary cutaneous melanoma in elderly patients.An Bras Dermatol. 2025 May-Jun;100(3):422-428. doi: 10.1016/j.abd.2024.07.017. Epub 2025 Apr 9. An Bras Dermatol. 2025. PMID: 40210539 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical